Financial Highlights

• Turnover up 30% to £297million (1999: £228million)

• EBITDA up 31% to £51.1million (1999: £38.9million)

• £54.5million raised through a cash and vendor placing

• Adjusted earnings per share up 23% to 23.17p

• Telecoms and Media profits up 89%; Biomedical and Pharmaceuticals up 133%

• Flagship pharmaceutical journal acquisition announced - "BioTechniques"
  

Informa Group's Chairman Peter Rigby commented:

"This record result reflects the quality of the business information we generate, the strength of our leading niche brands across six international marketplaces and the synergies which we are continuing to exploit between our publications and our events. We are looking forward to another successful year in 2001."

Enquiries
Peter Rigby/David Gilbertson/Jim Wilkinson
Informa Group plc	020 7453 2222
Lydia Pretzlik/Fiona Piper	020 7379 5151
The Maitland Consultancy

To view the complete release in pdf format Click here.

To view this file you will need to have Adobe Acrobat Reader installed. Click here to download the latest version of Adobe Acrobat Reader free.